NCT04358991View on ClinicalTrials.gov

Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Bacterial Infections
Interventions
DRUG

Ceftazidime-avibactam

collection of blood samples around clinical dosing immediately pre-dose, then at the following times thereafter: 1, 2, 4, 6, 8, and 12 hours and EMR review.

Trial Locations (1)

15213

UPMC, Pittsburgh

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

University of Pittsburgh

OTHER